Skip to main content
Top
Published in: Clinical Rheumatology 11/2018

01-11-2018 | Original Article

Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study

Authors: Xue Li, Yu-quan Qian, Na Liu, Rong Mu, Yu Zuo, Guo-chun Wang, Yuan Jia, Zhan-guo Li

Published in: Clinical Rheumatology | Issue 11/2018

Login to get access

Abstract

To investigate the clinical pattern, survival rate, causes of death and risk factors in a large cohort of Chinese Han patients with systemic sclerosis (SSc). Inpatients treated from 2002 to 2014 were included in this study. Patients were classified into diffuse cutaneous SSc (dcSSc), limited cutaneous SSc (lcSSc), and SSc-overlap syndrome groups. Data were analyzed using Chi-squared tests, Kaplan–Meier curves, log-rank tests, and Cox proportional hazards modeling. Among a total of 201 patients, dcSSc (50.2%) was the major subtype, followed by lcSSc (30.3%) and SSc-overlap (19.4%). Interstitial lung disease (ILD, 148/201, 74%) was the most frequent organ involvement. The overall survival rates were 98% and 95% at 5 and 10 years, respectively. The overall standard mortality ratio (SMR) was 2.22. The most common cause of death was ILD combined with infection (8/16, 50%), followed by kidney failure (2/16, 12.5%). On crude analysis, pulmonary hypertension, ILD, cardiac involvements, renal involvements, and digital ischemia were associated with poor prognosis. On multivariate analysis, pericardial effusion (p = 0.000) and digital ischemia (p = 0.016) were independent prognostic factors of death. The mortality rate of patients with SSc is mildly increased in comparison with the general population. ILD is the most common systemic involvement and the principal cause of death in SSc. Pericardial effusion and digital ischemia are independent factors associated with death.
Literature
1.
go back to reference LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202–205PubMed LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202–205PubMed
2.
go back to reference Moinzadeh P, Aberer E, Ahmadi-Simab K, Blank N, Distler JHW, Fierlbeck G, Genth E, Guenther C, Hein R, Henes J, Herich L, Herrgott I, Koetter I, Kreuter A, Krieg T, Kuhr K, Lorenz HM, Meier F, Melchers I, Mensing H, Mueller-Ladner U, Pfeiffer C, Riemekasten G, Sárdy M, Schmalzing M, Sunderkoetter C, Susok L, Tarner IH, Vaith P, Worm M, Wozel G, Zeidler G, Hunzelmann N, and all participating DNSS centers (2015) Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis 74(4):730–737CrossRef Moinzadeh P, Aberer E, Ahmadi-Simab K, Blank N, Distler JHW, Fierlbeck G, Genth E, Guenther C, Hein R, Henes J, Herich L, Herrgott I, Koetter I, Kreuter A, Krieg T, Kuhr K, Lorenz HM, Meier F, Melchers I, Mensing H, Mueller-Ladner U, Pfeiffer C, Riemekasten G, Sárdy M, Schmalzing M, Sunderkoetter C, Susok L, Tarner IH, Vaith P, Worm M, Wozel G, Zeidler G, Hunzelmann N, and all participating DNSS centers (2015) Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis 74(4):730–737CrossRef
3.
go back to reference Broen JC, Radstake TR, Rossato M (2014) The role of genetics and epigenetics in the pathogenesis of systemic sclerosis. Nat Rev Rheumatol 10(11):671–681CrossRef Broen JC, Radstake TR, Rossato M (2014) The role of genetics and epigenetics in the pathogenesis of systemic sclerosis. Nat Rev Rheumatol 10(11):671–681CrossRef
4.
go back to reference Steen V, Domsic RT, Lucas M, Fertig N, Medsger TA Jr (2012) A clinical and serologic comparison of African-American and Caucasian patients with systemic sclerosis. Arthritis Rheum 64(9):2986–2994CrossRef Steen V, Domsic RT, Lucas M, Fertig N, Medsger TA Jr (2012) A clinical and serologic comparison of African-American and Caucasian patients with systemic sclerosis. Arthritis Rheum 64(9):2986–2994CrossRef
5.
go back to reference Krzyszczak ME, Li Y, Ross SJ, Ceribelli A, Chan EKL, Bubb MR, Sobel ES, Reeves WH, Satoh M (2011) Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies. Clin Rheumatol 30(10):1333–1339CrossRef Krzyszczak ME, Li Y, Ross SJ, Ceribelli A, Chan EKL, Bubb MR, Sobel ES, Reeves WH, Satoh M (2011) Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies. Clin Rheumatol 30(10):1333–1339CrossRef
6.
go back to reference Rubio-Rivas M, Royo C, Simeón CP, Corbella X, Fonollosa V (2014) Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum 44(2):208–219CrossRef Rubio-Rivas M, Royo C, Simeón CP, Corbella X, Fonollosa V (2014) Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum 44(2):208–219CrossRef
7.
go back to reference Steen VD, Medsger TA (2007) Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 66(7):940–944CrossRef Steen VD, Medsger TA (2007) Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 66(7):940–944CrossRef
8.
go back to reference Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980) Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23(5):581–590CrossRef Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980) Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23(5):581–590CrossRef
9.
go back to reference Galie N, Hoeper MM, Humbert M et al (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 30(20):2493–2537CrossRef Galie N, Hoeper MM, Humbert M et al (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 30(20):2493–2537CrossRef
10.
go back to reference Rubio-Rivas M, Corbella X, Pestañafernández M et al (2018) First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study. Clin Rheumatol 37(4):999–1009CrossRef Rubio-Rivas M, Corbella X, Pestañafernández M et al (2018) First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study. Clin Rheumatol 37(4):999–1009CrossRef
11.
go back to reference Shu C, Du W, Mao X et al (2014) Possible single-nucleotide polymorphism loci associated with systemic sclerosis susceptibility: a genetic association study in a Chinese Han population. PLoS One 9(12):e113197CrossRef Shu C, Du W, Mao X et al (2014) Possible single-nucleotide polymorphism loci associated with systemic sclerosis susceptibility: a genetic association study in a Chinese Han population. PLoS One 9(12):e113197CrossRef
12.
go back to reference Wang J, Guo X, Yi L, Guo G, Tu W, Wu W, Yang L, Xiao R, Li Y, Chu H, He D, Jin L, Mayes MD, Zou H, Zhou X (2014) Association of HLA-DPB1 with scleroderma and its clinical features in Chinese population. PLoS One 9(1):e87363CrossRef Wang J, Guo X, Yi L, Guo G, Tu W, Wu W, Yang L, Xiao R, Li Y, Chu H, He D, Jin L, Mayes MD, Zou H, Zhou X (2014) Association of HLA-DPB1 with scleroderma and its clinical features in Chinese population. PLoS One 9(1):e87363CrossRef
13.
go back to reference Zhou XD, Yi L, Guo XJ, Chen E, Zou HJ, Jin L, Mayes MD, Assassi S, Wang JC (2013) Association of HLA-DQB1*0501 with scleroderma and its clinical features in Chinese population. Int J Immunopathol Pharmacol 26(3):747–751CrossRef Zhou XD, Yi L, Guo XJ, Chen E, Zou HJ, Jin L, Mayes MD, Assassi S, Wang JC (2013) Association of HLA-DQB1*0501 with scleroderma and its clinical features in Chinese population. Int J Immunopathol Pharmacol 26(3):747–751CrossRef
14.
go back to reference Walker UA, Tyndall A, Czirják L et al (2007) Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 66(6):754–763CrossRef Walker UA, Tyndall A, Czirják L et al (2007) Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 66(6):754–763CrossRef
15.
go back to reference Komocsi A, Vorobcsuk A, Faludi R et al (2012) The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies. Rheumatology 51(6):1027–1036CrossRef Komocsi A, Vorobcsuk A, Faludi R et al (2012) The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies. Rheumatology 51(6):1027–1036CrossRef
16.
go back to reference Mecoli CA, Shah AA, Boin F, Wigley FM, Hummers LK (2018) Vascular complications in systemic sclerosis: a prospective cohort study. Clin Rheumatol 37(9):2429–2437CrossRef Mecoli CA, Shah AA, Boin F, Wigley FM, Hummers LK (2018) Vascular complications in systemic sclerosis: a prospective cohort study. Clin Rheumatol 37(9):2429–2437CrossRef
17.
go back to reference Wangkaew S, Prasertwitayakij N, Phrommintikul A, Puntana S, Euathrongchit J (2017) Causes of death, survival and risk factors of mortality in Thai patients with early systemic sclerosis: inception cohort study. Rheumatol Int 37(12):2087–2094CrossRef Wangkaew S, Prasertwitayakij N, Phrommintikul A, Puntana S, Euathrongchit J (2017) Causes of death, survival and risk factors of mortality in Thai patients with early systemic sclerosis: inception cohort study. Rheumatol Int 37(12):2087–2094CrossRef
18.
go back to reference Mihai C, Landewe R, van der Heijde D et al (2016) Digital ulcers predict a worse disease course in patients with systemic sclerosis. Ann Rheum Dis 75(4):681–686CrossRef Mihai C, Landewe R, van der Heijde D et al (2016) Digital ulcers predict a worse disease course in patients with systemic sclerosis. Ann Rheum Dis 75(4):681–686CrossRef
19.
go back to reference Greiner S, Jud A, Aurich M, Hess A, Hilbel T, Hardt S, Katus HA, Mereles D (2014) Reliability of noninvasive assessment of systolic pulmonary artery pressure by Doppler echocardiography compared to right heart catheterization: analysis in a large patient population. J Am Heart Assoc 3(4):e001103CrossRef Greiner S, Jud A, Aurich M, Hess A, Hilbel T, Hardt S, Katus HA, Mereles D (2014) Reliability of noninvasive assessment of systolic pulmonary artery pressure by Doppler echocardiography compared to right heart catheterization: analysis in a large patient population. J Am Heart Assoc 3(4):e001103CrossRef
20.
go back to reference Simeón CP, Armadans L, Fonollosa V, Solans R, Selva A, Villar M, Lima J, Vaqué J, Vilardell M (2003) Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology 42(1):71–75CrossRef Simeón CP, Armadans L, Fonollosa V, Solans R, Selva A, Villar M, Lima J, Vaqué J, Vilardell M (2003) Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology 42(1):71–75CrossRef
21.
go back to reference Pérez-Bocanegra C, Solans-Laqué R, Simeón-Aznar CP et al (2010) Age-related survival and clinical features in systemic sclerosis patients older or younger than 65 at diagnosis. Rheumatology 49(6):1112–1117CrossRef Pérez-Bocanegra C, Solans-Laqué R, Simeón-Aznar CP et al (2010) Age-related survival and clinical features in systemic sclerosis patients older or younger than 65 at diagnosis. Rheumatology 49(6):1112–1117CrossRef
Metadata
Title
Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study
Authors
Xue Li
Yu-quan Qian
Na Liu
Rong Mu
Yu Zuo
Guo-chun Wang
Yuan Jia
Zhan-guo Li
Publication date
01-11-2018
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 11/2018
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-018-4291-z

Other articles of this Issue 11/2018

Clinical Rheumatology 11/2018 Go to the issue